the changing landscape for her2 advanced breast cancer: clinical experience with anti-her2 agents
Published 3 weeks ago • 1 view plays • Length 34:43Download video MP4
Download video MP3
Similar videos
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
2:17:54
changing treatment landscape in hr her2 abc
-
5:32
medscapetv • going the distance with metastatic breast cancer - episode 1: the journey begins
-
1:49
overview of recent changes to the treatment landscape for her2-positive crc
-
4:28
the changing treatment landscape of her2 breast cancer
-
1:00
defining optimal therapy in high-risk early breast cancer #shorts
-
5:37
therapeutic landscape for patients with her2-positive breast cancer with active brain metastases
-
30:49
conceptualizing guidelines to manage patients with hr–positive, her2-negative early breast cancer
-
44:23
metastatic breast cancer: leveraging clinical pathways to navigate a complex treatment landscape:
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
5:55
decision-making in metastatic her2 breast cancer
-
2:43
margetuximab for the treatment of her2-positive breast cancer
-
56:42
research update for her2-positive mbc | 2021-2022 embrace mbc virtual forum series
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
1:01
dr. hamilton discusses challenges with approved treatments for her2-positive breast cancer
-
3:58
promise breast cancer clinical trial
-
55:48
new & supporting data for optimizing therapy in her2 breast cancer | dr. bagegni & dr. gradishar
-
1:30:06
moving toward expanded precision treatment of her2- or her3-driven breast, gi, lung & other cancers
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute